Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michihiko Kuwano

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
International Journal of Oncology|September 25, 2008
Growth inhibitory effects of pegylated IFN-alpha2b and 5-fluorouracil in combination on renal cell carcinoma cell lines in vitro and in vivoFukuko Moriya, Sachiko Ogasawara, Yuji Basaki, et al.
The Kurume Medical Journal|November 27, 2024
High Expression of NDRG1 is a Poor Prognostic Factor in Patients with Endometrial Endometrioid Carcinoma with Long-Term ObservationMorio Ijichi, Kimio Ushijima, Tomohiko Yamaguchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2005
Functional analysis of organic cation transporter 3 expressed in human placentaRyoko Sata, Hisakazu Ohtani, Masayuki Tsujimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2010
Molecular diagnosis of activating EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysisAkihiko Kawahara, Chizuko Yamamoto, Kazutaka Nakashima, et al.
Cancer Chemotherapy and Pharmacology|January 6, 2009
Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiationKoichi Azuma, Tetsuro Sasada, Akihiko Kawahara, et al.
Cancer Research|July 23, 2013
Erlotinib resistance in lung cancer cells mediated by integrin β1/Src/Akt-driven bypass signalingRina Kanda, Akihiko Kawahara, Kosuke Watari, et al.
Oncology Reports|July 14, 2005
Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cellsTeruhiko Fujii, Anna M Nakamura, Goro Yokoyama, et al.
Cancer Science|August 30, 2008
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophagesKoji Hiraoka, Michihisa Zenmyo, Kousuke Watari, et al.
Molecular Cancer Therapeutics|January 7, 2004
Genetic polymorphism at the 5' regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colonShuichi Taniguchi, Yasushi Mochida, Takeshi Uchiumi, et al.
The Kurume Medical Journal|March 9, 2025
Upregulated Nuclear Y-box Binding Protein-1 Expression is Closely Associated with Mammalian Target of Rapamycin Expression in Endometrial CancerTeruyuki Yoshimitsu, Shin Nishio, Jongmyung Park, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
International Journal of Oncology|September 25, 2008
Growth inhibitory effects of pegylated IFN-alpha2b and 5-fluorouracil in combination on renal cell carcinoma cell lines in vitro and in vivoFukuko Moriya, Sachiko Ogasawara, Yuji Basaki, et al.
The Kurume Medical Journal|November 27, 2024
High Expression of NDRG1 is a Poor Prognostic Factor in Patients with Endometrial Endometrioid Carcinoma with Long-Term ObservationMorio Ijichi, Kimio Ushijima, Tomohiko Yamaguchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2005
Functional analysis of organic cation transporter 3 expressed in human placentaRyoko Sata, Hisakazu Ohtani, Masayuki Tsujimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2010
Molecular diagnosis of activating EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysisAkihiko Kawahara, Chizuko Yamamoto, Kazutaka Nakashima, et al.
Cancer Chemotherapy and Pharmacology|January 6, 2009
Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiationKoichi Azuma, Tetsuro Sasada, Akihiko Kawahara, et al.
Cancer Research|July 23, 2013
Erlotinib resistance in lung cancer cells mediated by integrin β1/Src/Akt-driven bypass signalingRina Kanda, Akihiko Kawahara, Kosuke Watari, et al.
Oncology Reports|July 14, 2005
Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cellsTeruhiko Fujii, Anna M Nakamura, Goro Yokoyama, et al.
Cancer Science|August 30, 2008
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophagesKoji Hiraoka, Michihisa Zenmyo, Kousuke Watari, et al.
Molecular Cancer Therapeutics|January 7, 2004
Genetic polymorphism at the 5' regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colonShuichi Taniguchi, Yasushi Mochida, Takeshi Uchiumi, et al.
The Kurume Medical Journal|March 9, 2025
Upregulated Nuclear Y-box Binding Protein-1 Expression is Closely Associated with Mammalian Target of Rapamycin Expression in Endometrial CancerTeruyuki Yoshimitsu, Shin Nishio, Jongmyung Park, et al.
Pageof 15